Previous Article | Next Article ![]()
Infection and Immunity, June 2002, p. 2899-2907, Vol. 70, No. 6
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.6.2899-2907.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Zoonotic & Animal Pathogens Research Laboratory, Department of Medical Microbiology,1 Department of Veterinary Pathology, Easter Bush Veterinary Centre, University of Edinburgh, Edinburgh,2 Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom3
Received 6 December 2001/ Returned for modification 22 January 2002/ Accepted 22 February 2002
|
|
|---|
|
|
|---|
L. intracellularis is an obligate intracellular bacterial enteropathogen which is most closely related to Desulfovibrio spp. (13) and Bilophila wadsworthia (41). This relationship is based solely on 16S rRNA sequence comparisons, and further similarities between L. intracellularis and these other species have not yet been reported. Pathogenesis of L. intracellularis has not been well investigated; however, organisms cultured in vitro have been used successfully to reproduce the disease in vivo (21, 30, 32, 42, 43). This bacterium has a tropism for intestinal epithelial cells, and the major pathological consequence of infection is hyperplasia of infected epithelial cells (23). An interesting observation with L. intracellularis infections is the reported lack of a significant inflammatory responses (23) and little evidence for dissemination beyond the epithelium, both of which are atypical of infections with other enteroinvasive bacterial pathogens such as salmonellae, shigellae, Listeria monocytogenes, and Clostridium piliforme. The specific bacterial determinants which confer pathogenicity and cause these distinctive pathological effects are not known. Bacterial attachment and entry occur via the apical surface of immature epithelial cells in a process which appears to require a specific bacterial ligand-receptor interaction (33) and an endocytic process involving host cell actin polymerization (24). Once inside the cell, the bacteria escape from the vacuolar compartment into the cytoplasm, where they multiply and spread from cell to cell following cell division (23). At present, the determinants used by L. intracellularis to enter the cell, escape the vacuole, multiply intracytoplasmically, and modulate host cell function are not known.
Molecular characterization of L. intracellularis is rudimentary. Aside from reports of 16S ribosomal DNA sequence, isolation and sequence analysis of one further locus, the groES/EL operon, has been reported as a means to assess the phylogenetic position of L. intracellularis (7). To date, however, no progress has been made in understanding the pathogenic mechanisms of this important pathogen. Despite the use of molecular technologies to further the understanding of the pathogenic mechanisms of a number of important bacterial pathogens (5, 46), the development and use of such techniques to investigate obligately intracellular bacteria have been minimal so far. Here, we applied a range of PCR-based methodologies to identify and characterize a Lawsonia pathogenicity determinant. We sequenced, expressed, and initiated functional examinations of an L. intracellularis surface antigen, which we term LsaA. This factor demonstrated a role during attachment and entry of this bacterium into intestinal epithelial cells, and its expression was monitored in vitro and in vivo using reverse transcription-PCR (RT-PCR) and immunochemical procedures. This study represents the first study of gene expression and characterization of a pathogenicity determinant of this obligate intracellular pathogen.
(This work was presented in part at the 101st General Meeting of the American Society for Microbiology, 2001.)
|
|
|---|
, and XL1-Blue were used for maintaining recombinant plasmids and were routinely cultured on Luria-Bertani medium supplemented with ampicillin (100 µg ml-1) or kanamycin (50 µg ml-1) when appropriate. E. coli BL21 and BL21(DE3)pLysS were host strains for expression of recombinant LsaA fusion proteins. Strains were grown on Luria-Bertani medium containing ampicillin (50 µg ml-1) alone or in combination with chloramphenicol (35 µg ml-1). For hemolysis assays BL21 strains were grown under appropriate selection and inducing conditions on freshly prepared blood agar plates. General molecular methods. Chromosomal DNA was extracted from L. intracellularis strains by using a method described previously (28). Essentially, approximately 108 bacteria were harvested by centrifugation at 11,500 x g for 5 min. Pelleted cells were resuspended in 600 µl of TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0) supplemented with 0.5% (wt/vol) sodium dodecyl sulfate and 100 µg of proteinase K ml-1 and incubated for 1 h at 37°C. One hundred microliters of 5 M NaCl and 80 µl of cetyltrimethylammonium bromide-NaCl was then added, and incubation was continued for a further 10 min at 65°C. Extraction with chloroform-isoamyl alcohol (24:1; Sigma) and phenol-chloroform-isoamyl alcohol (25:24:1; Sigma) preceded DNA precipitation in ethanol by centrifugation at 13,000 x g for 15 min at 4°C. Alternatively, to isolate both DNA and RNA, Qiagen RNA and DNA isolation kits were used. Plasmid DNA was prepared using Qiagen miniprep columns. PCR products were ligated into plasmids pCR Blunt II-TOPO or pCR 4-TOPO (Invitrogen) as directed by the manufacturer. Restriction enzyme digestions were performed by standard techniques (28) using enzymes supplied by Promega. DNA transfer to nylon membranes (Boehringer Mannheim) and Southern blot hybridization were performed as described previously (28). Degenerate oligonucleotide primer PCR (DOP-PCR) was performed essentially as described previously (48) with primers DOP-for (CGCTGCAGCNTCNACNGGNGGNGGNTTTAC) and DOP-rev (CCAAGCTTCNGCCTCGAACTGNGGCTT). L. intracellularis DNA (100 ng) was added to a 100-µl PCR mixture consisting of 10 mM Tris-HCl (pH 8.3), 2.5 mM MgCl2, 50 mM deoxyribonucleotides, a 25 µM concentration of each primer, and 1 U of Taq polymerase (Gibco BRL). PCRs were performed for 40 cycles of 1 min at 94°C, 1 min at 40°C, and 2 min at 72°C, in a Genius thermocycler (Techne). The amplified products were analyzed directly by agarose gel electrophoresis (28). Specific DNA probes were digoxigenin labeled using the DNA DIG Labeling Kit (Boehringer Mannheim). The probes used in this study were PCR amplified using lsaA-specific forward and reverse primers LI05 and LI02 (CTAGTTTACGCTTTAGATGTT and CGCTGCAGCGAATCATCATTAGTTTT, respectively) and 16S rRNA-specific primers 16Sfor and16Srev (TAACGCGTTAAGCAC and AGGGTTGCGCTCGTTG, respectively) (6). The relative positions of primers LI02 and LI05 and other lsaA-specific primers are presented schematically in Fig. 1. Gel images were captured using the AlphaImager system (Flowgen) and processed through PaintShop Pro6.
|
View larger version (8K): [in a new window] |
FIG. 1. Schematic representation of the L. intracellularis lsaA gene. Relative positions and directions of primers used for PCR amplifications are shown with arrows. Primers DOP-for and DOP-rev were used for DOP-PCR. Primers LI02 and LI05 were used in RT-PCR and the first stage of semirandom PCR chromosome walking in combination with random primer AP1 or AP2 (not shown). Primers LI15 and LI14 were used as nested primers with SPI in second-stage semirandom PCR chromosome walking. Primers LI19-for and LI-end1 were used to amplify complete the lsaA gene. Primer sequences and amplification conditions are indicated in the text.
|
Sequencing and sequence analysis. PCR products were cloned into pCR Blunt II-TOPO or pCR 4-TOPO (Invitrogen) for automated sequencing from both strands using an ABI PRISM DYE Terminator Cycle Sequencing Kit (Perkin-Elmer) on a model 373A Sequence System (Applied Biosystems). Sequences obtained from overlapping products from both DOP-PCR (i.e., target gene internal fragment) and semirandom PCR chromosome walking (i.e., regions flanking the partial sequence) were assembled using DNASTAR. Data were obtained from multiple reads of the region, permitting validation of sequences obtained on different occasions. Once sequence information from overlapping PCR products was obtained, the complete lsaA gene was amplified with specifically designed primers LI19-for and LI-end1 (ATGGGGATCCATGAAAAAAAGC and CCTGCAGATATCAAGGAATATATTCTG, respectively), cloned, and sequenced for further confirmation of data. Sequence analyses were carried out using programs BLASTN, BLASTX, and CLUSTAL W (National Center for Biotechnology Information, Los Alamos, N.Mex.) available on the Internet.
Cloning, expression, and purification of recombinant LsaA. The full-length lsaA gene was amplified from Lawsonia by using primers LI19-for and LI-end1 (sequences are given above), which incorporate BamHI and PstI sites, respectively. The PCR product was ligated into pCR 4-TOPO (Invitrogen) according to the manufacturer's directions and transformed into E. coli TOP10. Plasmids were purified and, following confirmation of clones by restriction digestion and sequencing, further digested for subcloning into expression vectors. For cloning as a His fusion, pCR 4-TOPO containing complete lsaA was digested with BamHI and PstI and subjected to agarose gel electrophoresis, and the band of appropriate size was purified from the gel (GeneClean). The purified product was ligated into pRSETA (Invitrogen) which was restriction digested and purified similarly. For cloning as a glutathione S-transferase (GST) fusion, pCR 4-TOPO containing complete lsaA was digested with BamHI and EcoRI, electrophoresed, and purified as described above. The purified product was ligated into pGEX-4T-2 (Amersham Pharmacia Biotech) which was restriction digested and purified similarly. Plasmids containing inserts were termed pHLsaA and pGLsaA, respectively. The insert was sequenced to confirm both the lsaA sequence and in-frame cloning. For expression, pHLsaA and pGLsaA were transformed into E. coli BL21(DE3)pLysS or BL21, and transformants were cultured and induced as described by the supplier. His and GST fusion proteins were purified using the Xpress (Invitrogen) and GSTrap (Amersham Pharmacia Biotech) protein purification systems, respectively.
RT-PCR. Total RNA was extracted from purified L. intracellularis or from Lawsonia-infected pig ileum by using RNA-DNA purification columns (Qiagen). The infected pig ileal tissue was obtained from an experimental challenge of pigs performed for related investigations (30). The methods of RNA isolation were essentially the same in both cases, although when infected tissue was used as the starting material, a more rigorous homogenization was performed. Total RNA was treated with RNase-free DNase I (Sigma) for 15 min at 37°C, after which DNase I was heat inactivated by incubation at 65°C for 10 min. RNA (100 ng) was denatured by incubation at 65°C for 10 min prior to reverse transcription in a mixture (20 µl) which contained 1x buffer, 5 mM deoxynucleoside triphosphates, 25 µM primer, 10 U of RNase inhibitor, and 4 U of Omniscript reverse transcriptase (Qiagen) and was incubated at 37°C for 60 min. The primers LI02 and 16Srev were used to reverse transcribe Lawsonia lsaA or 16S rRNA, respectively. Ten microliters of the cDNA was then used for the PCRs with primers LI02 and LI05 for lsaA or 16Sfor and 16Srev for 16S rRNA transcripts. PCRs were carried out under standard conditions with Taq polymerase, and products were analyzed using acrylamide gel analysis to increase the sensitivity of detection (28).
Experimental infection of animals and monitoring of infection. Experimental challenges of both mice and pigs (30, 42) were carried out for related investigations of pathogenicity and immune responses during L. intracellularis infection. Small and large intestines were removed post mortem; short regions were fixed in 10% neutral buffered formalin for immunohistochemical analysis, and the remainder was frozen rapidly and stored at -70°C for preparation of DNA and RNA (see above). Immunohistochemical detection of L. intracellularis in fixed tissues was performed as described previously (42). Polyclonal rabbit antiserum (1080/76) or mouse monoclonal antibody VPM53 (25, 31) was used as the primary antibody, and detection was performed using the relevant secondary antibody systems (Mouse-on-Mouse or VectaStain ABC systems [Vector Labs]) according to the manufacturer's instructions. Following this, sections were counterstained with hematoxylin and then mounted in DePex (Merck). Tissues were examined histologically for features typical of L. intracellularis infection, i.e., intestinal epithelial hyperplasia and immunoreactive intracellular bacteria (L. intracellularis).
Immunoblotting. Blood from experimentally challenged and control animals (30, 42) was placed in heparinized vessels and then centrifuged (10,000 x g, 1 min) to remove cellular components prior to removal of plasma to fresh vials for storage at -20°C. Plasma samples were diluted 1:200 in phosphate-buffered saline (PBS) for immunoblotting. Hyperimmune polyclonal rabbit antiserum (1080/76) and monoclonal antibody VPM53 (specific for L. intracellularis strains) were used as control antibodies. Antigen [recombinant LsaA-His fusion purified from E. coli BL21(DE3)pLysS] (approximately 2.5 µg per lane) was electrophoresed on a 12.5% acrylamide gel over the whole gel width and then transferred to nitrocellulose membranes by using an Ancos Semidry blotter. Nitrocellulose membranes were assembled into a parallel blotting assembly (Bio-Rad). Molecular size standards were included routinely on gels, and after transfer to nitrocellulose membrane, lanes were excised and stained with amido black to determine molecular sizes of antigens. Incubation of membranes with primary antibody (plasma diluted 1:200) was carried out for 1 h with gentle shaking, after which it was aspirated. Wells were washed three times with PBS, and then secondary antibody (horseradish peroxidase-conjugated anti-mouse immunoglobulin; Serotec) diluted 1:4,000 was added and left for a further hour. This was removed, and membranes were washed again as described above. Membranes were then removed from the slot blot assembly, washed a further three times in PBS and once in distilled water, and then developed by addition of substrate (diaminobenzidine; Sigma). Once developed, blots were dried and photographed, and images were captured and processed as for agarose and acrylamide gels.
Hemolysin assays. Hemolysin assays were carried out in both agar and fluid formats (39). For agar assays, E. coli clones transformed with pHLsaA or pGLsaA or vectors without insert were cultured on blood agar plates with appropriate selection and induction and monitored for hemolysis for up to 72 h. In microtiter format, purified recombinant LsaA fusion proteins (up to 100 µg ml-1) in PBS were incubated with a 1% suspension of washed sheep erythrocytes for 2 or 24 h. Positive (PBS containing 1% Triton X-100) and negative (PBS) controls were incorporated. Following incubation, cell suspensions were centrifuged (10,000 x g, 2 min) to remove unlysed cells, and then hemoglobin release was monitored by measuring absorbance at 570 nm in a spectrophotometer (Cecil CE2021).
Nucleotide sequence accession number. The nucleotide sequence of the lsaA locus has been placed in the GenBank database under accession number AF498259.
|
|
|---|
) and Brachyspira hyodysenteriae were used as negative and positive controls, respectively. Products of 300 bp were amplified from all five strains of L. intracellularis examined (data not shown) and also from positive control DNA from B. hyodysenteriae, while no product was visible from the E. coli DNA. Thus, it appears that all available L. intracellularis isolates possess the genomic region representing this locus. Having detected this locus, we proceeded to determine the sequence around this 300-bp region. Semirandom PCR chromosome walking with biotinylated specific primers allowed amplification of DNA sequences adjacent to the region initially obtained. Arbitrary primers used in conjunction with biotinylated primer LI02b or LI05b amplified upstream and downstream flanking regions, respectively. Using this approach, sequences for adjacent upstream (ca. 1-kbp) and downstream (ca. 400-bp) regions were obtained to give a region of ca. 1.7 kbp. Sequence comparison and analysis of L. intracellularis gene product. Sequence analysis of the ca. 1.7-kbp region showed only one complete putative open reading frame (ORF) which encompassed the original DOP-PCR product. Sequence comparisons of the deduced amino acid sequence of this putative ORF using BLASTX showed some similarity with a family of bacterial proteins and putative proteins for which B. hyodysenteriae TlyA represents the prototype (27, 35, 44). Regions upstream and downstream from this putative ORF revealed similarities to three other bacterial sequences (deoB, nusB, and nifS); however, none of these represented possible complete ORFs. Sequences with similarity to tlyA are present within the genomes of a diverse range of bacteria, including Mycoplasma pulmonis (4), Mycoplasma hyopneumoniae (GenBank accession no. AAG46052), B. hyodysenteriae (27, 35, 44), Rickettsia prowazekii (2), Ureaplasma urealyticum (14), Streptococcus pyogenes (10), Borrelia burgdorferi (11), Helicobacter pylori (1, 29, 45), Campylobacter jejuni (38), Mycobacterium tuberculosis (47), and Mycobacterium leprae (9). The L. intracellularis ORF showed greatest similarity to homologues in two Mycoplasma species, M. pulmonis (53.3% identity) and M. hyopneumoniae (49.6% identity), which are phylogenetically distinct from Lawsonia. Alignment of the deduced amino acid sequence of the L. intracellularis ORF with those of M. pulmonis and M. hyopneumoniae is shown in Fig. 2a.
![]() View larger version (66K): [in a new window] |
FIG. 2. Sequence comparison of the L. intracellularis LsaA protein. The deduced amino acid sequence of L. intracellularis LsaA was aligned with TlyA sequences from other bacteria by using CLUSTAL W. Amino acids are written in single-letter convention; asterisks, colons, and periods represent identical, conserved, and semiconserved residues, respectively. (a) Alignment with M. pulmonis (Mpulm) (accession number NP326002) and M. hyopneumoniae (Mhyo) (accession number AAG46052). (b) Alignment with B. hyodysenteriae (Bhyo) (accession number Q06803), M. tuberculosis (Mtb) (accession number X98295), and H. pylori (Hp26695) (accession number AAD08129).
|
Monoclonal antibody VPM53 to L. intracellularis reacted with purified recombinant ORFA-His fusion (Fig. 3). This antibody recognized a surface protein of L. intracellularis of approximately 27 kDa (25, 31-33), which corresponds closely to the calculated molecular mass of this gene product (27.4 kDa) based on the deduced amino acid sequence. Both the monoclonal antibody and its Fab fragment substantially inhibited L. intracellularis in vitro infectivity, to below 10 and 1%, respectively (33), indicating a role for this product in attachment to and/or invasion of intestinal epithelial cells, a phenotype which was not predicted from sequence comparison. The terminology lsaA-LsaA, for Lawsonia surface antigen A, is proposed for this gene and its product.
![]() View larger version (116K): [in a new window] |
FIG. 3. Reactivity of LsaA with monoclonal antibody and sera from infected animals. Monoclonal antibody VPM53 and rabbit hyperimmune polyclonal serum 1080/76 (lanes 1 and 3, respectively) reacted with recombinant LsaA (ca. 27 kDa). Lanes 2 and 4, control lanes incubated with labeled anti-mouse or anti-rabbit secondary antibody but without primary antibody. Sera from animals experimentally infected with L. intracellularis (lanes 5 to 7) reacted specifically with LsaA, whereas sera from uninfected animals (lanes 8 to 10) did not; induction of specific antibodies indicates that LsaA was expressed during infection. Lane 11, control lane incubated with labeled anti-mouse antibody but without primary antibody. Lane 12, molecular size standards separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to nitrocellulose as for LsaA and then removed and stained with amido black. Sizes (in kilodaltons) are indicated at the right.
|
![]() View larger version (34K): [in a new window] |
FIG. 4. Transcriptional analysis of 16S rRNA (odd-numbered lanes) and lsaA (even-numbered lanes) in L. intracellularis grown in vitro. (a) The presence of L. intracellularis in infected IEC18 cells was confirmed by conventional PCR amplification of 16S rRNA and lsaA from extracted DNA. (b) RT-PCR with 16S rRNA- or lsaA-specific primers detected transcripts for both 16S rRNA and lsaA in RNA extracted from IEC18 cells infected with L. intracellularis. (c and d) Products obtained from RT-PCR amplification of 16S rRNA and lsaA were separated by electrophoresis and transferred to a nylon membrane for Southern blotting. Blotting was performed with digoxigenin-labeled 16S rRNA-specific (c) or lsaA-specific (d) probes, and the presence of single bands in each panel confirmed the specificity of the RT-PCR.
|
![]() View larger version (82K): [in a new window] |
FIG. 5. Transcriptional analysis of 16S rRNA and lsaA during infection in vivo. (a and b) Conventional PCR amplification of 16S rRNA (a) and lsaA (b) was performed with DNA extracted from ileum of L. intracellularis-infected (lanes 1 to 5) and uninfected (lanes 6 to 9) animals. Amplification products of 600 and 300 bp for 16S rRNA and/or lsaA, respectively, were evident only in DNA from infected animals. (c to f) Transcriptional analysis of L. intracellularis 16S rRNA (c and d) and lsaA (e and f) in RNA extracted from L. intracellularis-infected animals L1 (lanes 1 and 2), L2 (lanes 3 and 4), L3 (lanes 5 and 6), L4 (lanes 7 and 8), and L5 (lanes 9 and 10). Odd-numbered lanes indicate RT-PCRs in which reverse transcriptase was incorporated, while even-numbered lanes represent the reaction without reverse transcriptase (control). Products were separated by polyacrylamide gel electrophoresis. Only the relevant regions of the gels are shown. RT-PCR with primers specific for 16S rRNA (c) was confirmed by Southern blotting with a 16S rRNA probe (d) and that with primers specific for lsaA (e) was confirmed by Southern blotting with an lsaA probe (f).
|
Analysis of lsaA transcription in vivo by RT-PCR using Lawsonia-infected and uninfected pig tissue requires similar stringency. Tissues obtained from animals determined to be infected (L1 to L5) or uninfected (N1 to N4) by immunohistochemical detection (data not shown) were used for DNA and RNA extraction. Like for infected cell monolayers, the presence of 16S rRNA and lsaA genes (and hence bacteria) was determined by conventional PCR analysis with DNA as the template. Animals assessed as infected by immunohistochemistry also demonstrated the presence of 16S rRNA and lsaA PCR products, whereas uninfected animals did not (Fig. 5a and b) did not. We proceeded to examine these animals for transcripts of 16S rRNA and lsaA by using highly purified RNA extracted from the infected pig tissue. Products were obtained with both the 16S rRNA-specific and lsaA-specific primers in all samples from infected animals (Fig. 5c and e, respectively) but not in those from uninfected animals. Again the reactions with no reverse transcription produced no products, confirming the absence of contaminating DNA. The specificity of these products was shown by Southern analysis as before (Fig. 5d and f). RT-PCR therefore demonstrated that Lawsonia 16S rRNA and lsaA were transcribed by these bacteria in the in vivo environment.
The region upstream from the proposed start codon of the Lawsonia lsaA was examined for motifs typical of promoter regions; however, neither conventional sigma factor consensus sites nor ribosome-binding sites were identified. This may reflect peculiarities in gene regulation and expression in this bacterium as a result of its phylogenetic position and its lifestyle. Further analysis is required to fully characterize promoter regions of this and other genes of this bacterium.
To determine whether LsaA protein was expressed by L. intracellularis during infection, two immunochemical approaches were taken. First, sera from mice experimentally infected with L. intracellularis LR189/5/83 (42) were examined by immunoblotting for antibodies to purified recombinant LsaA. The results showed that uninfected mice did not possess antibodies to this protein, whereas animals infected with L. intracellularis did (Fig. 3). Similar results were obtained with sera from experimentally infected pigs (data not shown). The mounting of a specific serum immune response by animals orally inoculated with L. intracellularis demonstrated that this protein is indeed expressed during infection. Further evidence that LsaA was expressed during infection was obtained with monoclonal antibody VPM53, which reacted with intracellular L. intracellularis in situ in both cell culture and infected animals (Fig. 6). As described above, this antibody specifically recognizes LsaA (Fig. 3), which is a ca. 27-kDa surface antigen of this bacterium. Together, the results from these immunochemical studies confirm that LsaA is expressed by L. intracellularis under both in vitro and in vivo circumstances.
![]() View larger version (75K): [in a new window] |
FIG. 6. Expression of LsaA by L. intracellularis during infection. L. intracellularis cultured either in vitro in IEC18 cells (left panel) or in infected intestinal epithelium (right panel) reacted with monoclonal antibody VPM53, which recognizes LsaA (Fig. 3). Immunohistochemical detection shows L. intracellularis as more darkly staining cells and aggregates. Examples of heavily infected cells and intestinal crypts are indicated by arrowheads, and uninfected cells and crypts are indicated by asterisks. Typically, infection of crypts is accompanied by epithelial hyperplasia, whereas adjacent uninfected crypts show normal structure as seen in the right panel.
|
|
|
|---|
We identified and sequenced an L. intracellularis ORF by using DOP-PCR and semirandom PCR chromosome walking and have termed this ORF lsaA, since it encodes a Lawsonia surface antigen which we have shown to be associated with attachment to and/or entry into epithelial cells. Identification of this gene was followed by examination of its expression and initial assessment of its function during infection. RT-PCR has been the method used most widely to monitor gene expression in obligate intracellular bacteria, and its application detected gene transcription by L. intracellularis in both in vitro (infected IEC18 cells) and in vivo (tissue from infected animals) environments. Our results clearly show that both genes encoding 16S rRNA and lsaA are transcribed during infection of intestinal epithelial cells in vitro (Fig. 4). Conditions are much more complex in vivo, and expression of genes may differ from that in in vitro environments; therefore, we examined expression of these genes in ileal tissue from infected pigs. Similar to infection in vitro, transcripts specific to both 16S rRNA and lsaA were detected (Fig. 5). Detection of 16S rRNA- and lsaA-specific transcripts indicated that these genes were expressed and suggested that both are functional during infection. The former clearly performs an essential role in protein synthesis and is presumably transcribed by metabolically active bacteria, whereas understanding of a role(s) for the latter was part of this investigation.
Although it is generally considered that transcription and translation are coupled in bacteria, expression of LsaA protein itself was assessed as a confirmatory procedure. We demonstrated that monoclonal antibody VPM53 recognized recombinant LsaA (Fig. 3), thus facilitating the study of protein expression by immunochemical means. This anti-LsaA monoclonal antibody reacted with intracellular L. intracellularis grown in epithelial cell monolayers or in infected intestinal tissue (Fig. 6); thus, LsaA is expressed under conditions prevailing during both in vitro and in vivo infection. Further corroboratory evidence for expression of LsaA in vivo was obtained from animals (pigs and mice) orally inoculated with L. intracellularis: plasma from infected animals contained antibodies recognizing recombinant LsaA (Fig. 3), thus confirming that LsaA protein was expressed by L. intracellularis during infection.
Demonstration of protein expression does not, in itself, confirm a function(s) or role(s) in pathogenesis; therefore, possible phenotypic characteristics of LsaA were assessed. The deduced amino acid sequence of LsaA was compared to sequence databases. LsaA demonstrated low, though notable, similarity to bacterial proteins within the recently identified TlyA family which are present in a range of phylogenetically diverse bacterial pathogens. Amino acid identity ranged from ca. 50% with M. pulmonis (4) and M. hyopneumoniae (GenBank accession no. AAG46052) to approximately 23% with M. leprae (9); thus, these proteins (and deduced proteins) show much sequence diversity, and such heterogeneity may be of significance.
Although sequence heterogeneity is evident, the presence of representatives of this protein family among these bacteria presumably reflects an important function for these bacteria. To date, homologues from only three bacterial species, i.e., B. hyodysenteriae, M. tuberculosis, and H. pylori, have been examined functionally. Among the activities conferred by TlyA cloned from these bacteria was hemolysis (18, 29, 35, 44, 47); however, neither recombinant E. coli clones expressing L. intracellularis LsaA nor purified recombinant LsaA protein exhibited a hemolytic phenotype. Since there is significant amino acid sequence divergence between the B. hyodysenteriae (36.7% identity [35]), H. pylori (33.8% identity for strain 26995 [29, 45] and 31.7% identity for strain J99 [1]), and M. tuberculosis (26.5% identity [47]) gene products and that of L. intracellularis, this distinct phenotype should perhaps not be entirely unexpected. Recently it was proposed that rather than directly conferring a hemolytic phenotype, TlyA may be a regulatory factor (17), a suggestion which is corroborated through sequence similarities of the N-terminal region of this protein with nucleic acid binding proteins. Irrespective of its specific function, TlyA deletion mutants pf B. hyodysenteriae are significantly attenuated (19) and similarly, H. pylori TlyA mutants show reduced colonization of mice (29); however, a similar function has yet to be ascribed to this gene product in M. tuberculosis.
These proteins evidently confer pathogenicity-associated characteristics, although specific activities and functions need to be examined further. Our own studies of phenotypic characteristics of L. intracellularis LsaA suggest a function for this protein in interaction with epithelial cells. In this study we have shown that L. intracellularis-specific monoclonal antibody VPM53 recognized LsaA, a protein of ca. 27 kDa. This monoclonal antibody also demonstrated reactivity with a bacterial outer membrane component of 27 kDa (31, 32); thus, LsaA is a surface-associated antigen. Furthermore, this anti-LsaA monoclonal antibody inhibited L. intracellularis infection of intestinal epithelial cells in vitro (33), therefore blocking a specific ligand-receptor interaction, with the ligand being LsaA. Similarly, the TlyA orthologue of H. pylori was shown to have significance in adherence to gastric epithelial cells (29), and although its direct involvement in association with epithelium was not examined, that report corroborates our own findings that members of this family may act as possible colonization factors.
Together, our accumulated information indicates that LsaA is a surface molecule of L. intracellularis which plays a role early in infection, presumably conferring adherence and/or invasion. Involvement of LsaA in attachment and/or entry was not anticipated from primary structure comparison, and with the demonstration of this phenotype, it is clear that the function(s) of this protein family requires further elucidation. Since most of the other members of this group of presumed proteins have been identified from genome sequencing, their expression remains presumptive and phenotypes remain to be examined; thus, potential role(s) has yet to be fully defined.
This is the first report of an L. intracellularis factor implicated as a pathogenicity determinant, and its identification has furthered our understanding of the mechanisms of infection of this bacterium. In this study we have identified lsaA as a gene which is both transcribed and translated by L. intracellularis during infection. This is the first direct demonstration of expression of any gene in this novel species of obligate intracellular bacteria and represents a significant initial step in more detailed analyses of expression and regulation of this and other L. intracellularis genes, including those encoding potential pathogenicity determinants. Although further analysis will be required to define fully the role of this factor, our results indicate that LsaA is important in the pathogenesis of L. intracellularis, as it is evidently involved during attachment to and/or invasion of epithelial cells.
We thank I. Bennett for sequencing of clones; N. MacIntyre, S. Mitchell, and S. Rhind for their contributions to in vivo studies; and the staff of the Experimental Pathogens Unit for their excellent technical support (all from the Department of Veterinary Pathology, University of Edinburgh).
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»